Guosheng Cao
6PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jul 02, 2025
Correction to "Atractylenolide-1 Alleviates Ulcerative Colitis via Restraining RhoA/ROCK/MLC Pathway-Mediated Intestinal Barrier Dysfunction".Zengxiang Gao, Xuecheng Yu, Wenlong Su
|May 14, 2025
Atractylenolide-1 Alleviates Ulcerative Colitis via Restraining RhoA/ROCK/MLC Pathway-Mediated Intestinal Barrier Dysfunction.Zengxiang Gao, Xuecheng Yu, Wenlong Su
|Dec 23, 2022
Protective Effects of Atractylodis lancea Rhizoma on Lipopolysaccharide-Induced Acute Lung Injury via TLR4/NF-κB and Keap1/Nrf2 Signaling Pathways In Vitro and In Vivo.Kun Shi, Yangxin Xiao, Yan Dong
|Jan 30, 2021
Pharmacogenetics of tamoxifen therapy in Asian populations: from genetic polymorphism to clinical outcomes.Tingyu Wang, Yitian Zhou, Guosheng Cao
|Feb 14, 2018
YiQiFuMai Powder Injection Protects against Ischemic Stroke via Inhibiting Neuronal Apoptosis and PKCδ/Drp1-Mediated Excessive Mitochondrial Fission.Yingqiong Xu, Yan Wang, Guangyun Wang
|Apr 19, 2016
YiQiFuMai Powder Injection Ameliorates Cerebral Ischemia by Inhibiting Endoplasmic Reticulum Stress-Mediated Neuronal Apoptosis.Guosheng Cao, Huana Zhou, Nan Jiang
Pageof 1
